Aptar, a global leader in drug delivery, consumer product dispensing and active packaging solutions, is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows easy disinfecting of N95 filtering facepiece respirators (N95 mask). The N95 masks are desperately needed by healthcare personnel due to the shortage of disposable masks during the COVID-19 pandemic.
In this simple disinfecting process, the N95 mask and a small strip of Aptar’s ActivShieldTM are placed inside any commonly available one-gallon plastic bag.